glp 1 agonist drug interactions A Comprehensive Review on the Pharmacokinetics and Drug−Drug of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Advances in GLP-1 receptor agonists:
Description
Coverage for obesity indications (Wegovy, Saxenda, Zepbound) remains more limited
GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 44.Pirro V, Roth KD, Lin Y, Willency JA, Milligan PL, Wilson JM, Ruotolo G, Haupt A, Newgard CB, Duffin KL
These interventions have shown promise in maintaining muscle mass and function during pharmacologically induced weight loss
Rosenstock J, Ferrannini E
